Hamaguchi, Masahide

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Saito, T., Nishikawa, H., Wada, H., Nagano, Y., Sugiyama, D., Atarashi, K., Maeda, Y., Hamaguchi, M., Ohkura, N., Sato, E., et al. (2016) · Nature Medicine

T-cell and B-cell ImmunologyCancer Immunotherapy and Biomarkers

Cited by 871

FANTOM5 CAGE profiles of human and mouse samples

Noguchi, S., Arakawa, T., Fukuda, S., Furuno, M., Hasegawa, A., Hori, F., Ishikawa-Kato, S., Kaida, K., Kaiho, A., Kanamori-Katayama, M., et al. (2017) · Scientific Data

Genomics and Chromatin DynamicsGenomics and Phylogenetic Studies

Cited by 310

Group 3 innate lymphoid cells protect steatohepatitis from high-fat diet induced toxicity

Hamaguchi, M., Okamura, T., Fukuda, T., Nishida, K., Yoshimura, Y., Hashimoto, Y., Ushigome, E., Nakanishi, N., Majima, S., Asano, M., et al. (2021) · Frontiers in Immunology

IL-33, ST2, and ILC PathwaysLiver Disease Diagnosis and Treatment

Cited by 47

Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes

Ushigome, E., Yamazaki, M., Hamaguchi, M., Ito, T., Matsubara, S., Tsuchido, Y., Kasamatsu, Y., Nakanishi, M., Fujita, N., & Fukui, M. (2021) · Diabetes Technology & Therapeutics

Diabetes Management and ResearchHyperglycemia and glycemic control in critically ill and hospitalized patients

Cited by 40

Characteristics of chronic fatigue syndrome in a Japanese community population: Chronic fatigue syndrome in Japan

Hamaguchi, M., Kawahito, Y., Takeda, N., Kato, T., & Kojima, T. (2011) · Clinical Rheumatology

Fibromyalgia and Chronic Fatigue Syndrome ResearchLong-Term Effects of COVID-19

Cited by 34

The visceral adiposity index is a predictor of incident nonalcoholic fatty liver disease: A population-based longitudinal study

Okamura, T., Hashimoto, Y., Hamaguchi, M., Obora, A., Kojima, T., & Fukui, M. (2020) · Clinics and Research in Hepatology and Gastroenterology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 32